← Back to Search

Focused Ultrasound

Focused Ultrasound for Epilepsy (LIFUS Trial)

N/A
Recruiting
Led By Ellen J Bubrick, MD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects with drug-resistant temporal lobe epilepsy whose seizures involve altered awareness (ie failed at least two trials of antiepileptic drugs for seizures), as determined by one of the BWH epilepsy neurologists based on clinical seizure semiology and/or EEG findings.
Subjects who experience at least 1-2 seizures per month on average, are aware of or have reliable caregivers who are aware of when seizures occur and can reliably log seizure frequency
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Summary

This trial aims to see if a new ultrasound treatment can help epilepsy patients who haven't been helped by drugs.

Who is the study for?
This trial is for adults with drug-resistant temporal lobe epilepsy, experiencing 1-2 seizures monthly. Participants must be able to log seizure frequency and understand the consent form. They should have failed at least two antiepileptic drug trials.
What is being tested?
The study tests the tolerability and effectiveness of Pulsed Low-Intensity Focused Ultrasound (PLIFUS) on patients with drug-resistant temporal lobe epilepsy through moderate term, repeated exposure.
What are the potential side effects?
Potential side effects are not explicitly listed in the provided information but may include discomfort or other symptoms related to ultrasound exposure which participants will report during or after treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have temporal lobe epilepsy that hasn't improved with at least two different seizure medications.
Select...
I have 1-2 seizures monthly and can track them myself or with help.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Effect of PLIFUS on patient EEG (evaluate number of attenuated epileptiform discharges)
Efficacy of PLIFUS in reducing seizure frequency
Patient tolerability of moderate term, repeated exposure toPulsed Low-Intensity Focused Ultrasound (PLIFUS) (Adverse Events assessment)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Drug-Resistant Epilepsy (temporal lobe)Experimental Treatment1 Intervention
Pulsed low intensity focused ultrasound

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,653 Previous Clinical Trials
11,491,025 Total Patients Enrolled
11 Trials studying Epilepsy
54,303 Patients Enrolled for Epilepsy
Ellen J Bubrick, MD3.76 ReviewsPrincipal Investigator - Brigham and Women's Hospital
Brigham and Women's Hospital
1Patient Review
Dr. Bubrick put me in danger by threatening to have me hospitalized on Friday, August 30th, 2014, after my operation. This caused me to have a seizure on my 90 year old neighbor's floor. She said, "Shelley, you are alright, you do not need to be here in the emergency room, or readmitted to the hospital! I have two choices for you, and I hope you choose the right one! The first choice is to go home, and I hope that you do, because the next choice is a psychiatric hospitalization"!!!!! Dr. Bubrick never attended the meeting with my former PC
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top